(Q52032915)

English

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

scientific article published in June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. (English)

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

author name string

Cartwright K

1

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Morris R

2

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Rümke H

3

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Fox A

4

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Borrow R

5

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Begg N

6

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Richmond P

7

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Poolman J

8

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

17

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

20-21

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

2612-2619

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Reliability of notification data for childhood bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of Neisseria meningitidis Group B into Distinct Serotypes. III. Application of a New Bactericidal-Inhibition Technique to Distribution of Serotypes among Cases and Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of Antibodies to Meningococcal Protein and Lipopolysaccharide Serotype Antigens in Healthy Carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response of infants and children to disseminated infections with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Age incidence of meningococcal infection England and Wales, 1984-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900044-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(99)00044-4

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

1 reference

Europe PubMed Central

20 April 2018

http://europepmc.org/abstract/MED/10418910

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52032915&oldid=1775336288"